Halozyme(HALO)
$95.97-0.53 (-0.55%)
HALO
Halozyme ownership
$95.97
At close:-0.53 (-0.55%)
Want to see HALO full AI Analyst Report?
Halozyme (HALO) Ownership - Who Owns Halozyme?
1,272 Followers
Halozyme (HALO) Ownership Overview
- 0.92% Insiders
- 30.79% Mutual Funds
- 32.15% Other Institutional Investors
- 30.37% ETFs
- 5.78% Public Companies and Individual Investors
The ownership structure of Halozyme (HALO) stock is a mix of institutional, retail, and individual investors. Approximately 93.30% of the company’s stock is owned by Institutional Investors, 0.92% is owned by Insiders, and 5.78% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Halozyme (HALO) stock is a mix of institutional, retail, and individual investors. Approximately 93.30% of the company’s stock is owned by Institutional Investors, 0.92% is owned by Insiders, and 5.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 09, 2026 | Cortney Caudill | $1,955,137 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Hussman Strategic Advisors Inc | $2,782,080 | |
| Sep 30, 2026 | Gallacher Capital Management Llc | $328,109 | |
| Sep 30, 2026 | Bridgewater Associates, Lp | $36,240,898 | |
| Sep 30, 2026 | Driehaus Capital Management Llc | $5,302,622 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 13,668,566 | Institution | 11.99% | 1,311,772,279 |
| Ishares | 13,144,030 | Institution | 11.53% | 1,261,432,559 |
| Vanguard Index Funds | 9,410,725 | Institution | 8.25% | 903,147,278 |
| Vanguard | 9,173,479 | Institution | 8.05% | 880,378,780 |
| Spdr | 3,771,343 | Institution | 3.31% | 361,935,788 |
| Delaware Group Equity Funds V | 3,056,123 | Institution | 2.68% | 293,296,124 |
| First Trust | 1,511,187 | Institution | 1.33% | 145,028,616 |
| John Hancock Funds Iii | 1,430,565 | Institution | 1.25% | 137,291,323 |
| Schwab | 1,181,638 | Institution | 1.04% | 113,401,799 |
| T. Rowe Price Quantitative Management Funds, Inc. | 1,175,300 | Institution | 1.03% | 112,793,541 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 9,410,725 | Institution | 8.25% | 903,147,278 |
| Delaware Group Equity Funds V | 3,056,123 | Institution | 2.68% | 293,296,124 |
| John Hancock Funds Iii | 1,430,565 | Institution | 1.25% | 137,291,323 |
| T. Rowe Price Quantitative Management Funds, Inc. | 1,175,300 | Institution | 1.03% | 112,793,541 |
| Fidelity Concord Street Trust | 1,174,751 | Institution | 1.03% | 112,740,853 |
| Capitol Series Trust | 1,141,605 | Institution | 1.00% | 109,559,832 |
| Tiaa-cref Funds | 1,011,291 | Institution | 0.89% | 97,053,597 |
| Vanguard Explorer Fund | 832,286 | Institution | 0.73% | 79,874,487 |
| Fidelity Salem Street Trust | 759,139 | Institution | 0.67% | 72,854,570 |
| Dfa Investment Dimensions Group Inc | 756,531 | Institution | 0.66% | 72,604,280 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| iShares S&P Mid-Cap ETF CDI, AU:IJH ETF | 4,200,163 | Institution | 3.68% | 138,017,356 |
| iShares Core S&P Mid-Cap ETF, IJH ETF | 4,100,610 | Institution | 3.60% | 393,535,542 |
| Vanguard Total Stock Market ETF, VTI ETF | 2,844,856 | Institution | 2.50% | 372,420,099 |
| Vanguard Small-Cap ETF, VB ETF | 2,544,647 | Institution | 2.23% | 333,119,739 |
| Vanguard Small-Cap Growth ETF, VBK ETF | 1,424,938 | Institution | 1.25% | 186,538,634 |
| SPDR S&P BIOTECH ETF, XBI ETF | 1,419,740 | Institution | 1.25% | 137,004,910 |
| Vanguard Extended Market ETF, VXF ETF | 1,286,717 | Institution | 1.13% | 168,444,122 |
| First Trust NYSE Arca Biotechnology Index Fund, FBT ETF | 894,772 | Institution | 0.78% | 85,871,269 |
| iShares Biotechnology ETF, IBB ETF | 876,714 | Institution | 0.77% | 84,138,243 |
| State Street SPDR S&P MidCap 400 ETF Trust, MDY ETF | 847,944 | Institution | 0.74% | 81,377,186 |
FAQ
Who Owns Halozyme (HALO)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 93.30% of the company's stock is held by institutional investors, 0.92% is held by insiders, and 5.78% is held by public companies and individual investors.
What percentage of Halozyme (HALO) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 93.30% of Halozyme (HALO) stock is held by institutional investors: 30.79% by mutual funds, 30.37% by ETFs and 32.15% by other institutional investors.
What percentage of Halozyme (HALO) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 5.78% of Halozyme (HALO) stock is held by public companies and individual investors.
Who owns the most shares of Halozyme (HALO)?
BlackRock, Inc. owns the most shares of Halozyme (HALO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

